Nooshin K. Brinster

Nooshin K. Brinster

Auto-generated profile, based on publicly available information

Nooshin K. Brinster

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2021 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
VLValerie Larson
Valerie Larson
RSRoy Seidenberg
Roy Seidenberg
ACAvrom Caplan
Avrom Caplan
NBNooshin K. Brinster
Nooshin K. Brinster
SMShane A. Meehan
Shane A. Meehan
Randie KimRandie Kim
Randie Kim

1 February 2020 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
Randie KimRandie Kim
Randie Kim
NBNooshin K. Brinster
Nooshin K. Brinster
Direct immunofluorescence (DIF) remains a valuable tool that may be underused because of perceived challenges in the interpretation, limitations, and processing of DIF specimens. The aim of this review is to provide a practical guide for appropriately incorporating DIF in a variety of clinical diseases, such as autoimmune blistering disorders. In vasculitis, the role of DIF continues to evolve, particularly in the setting of IgA vasculitis. Although typically not indicated for the workup of connective tissue disease, DIF may be helpful in cases with negative serologies, nondiagnostic histologic findings, or scarring alopecia. Practical pearls for biopsy technique, specimen handling, and storage are also discussed.

30 June 2020 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
ANAriella R. Ba Noorily
Ariella R. Ba Noorily
MCMaressa C. Criscito
Maressa C. Criscito
JCJeffrey M. Cohen
Jeffrey M. Cohen
NBNooshin K. Brinster
Nooshin K. Brinster
Background: Dermatopathologists sometimes encounter patients with features of psoriasis vulgaris and additional changes of eczematous dermatoses. These cases are challenging to diagnose, and the clinical implications are unclear. In the age of targeted therapy, it is important to improve our understanding of these findings so that patients are managed appropriately. Objective: To characterize the clinical characteristics, histopathological features, diagnostic workup, successful treatment, and outcomes of patients with overlapping histopathologic features of psoriasis vulgaris and eczema. Methods: We conducted a retrospective chart review of 20 patients who had received the histopathologic diagnosis of psoriasis vulgaris with eczematous changes noted on skin biopsy. A database that included information about clinical characteristics, comorbidities, histopathological features, diagnostic workup, treatment modalities, and outcomes was created and analyzed. Results: Twenty patients were included in this study, with an average age of 57.3 years. After clinicopathologic correlation, most patients were diagnosed with psoriasis (85%), and the remainder were determined to have an eczematous dermatitis. Thirty-five percent of patients were diagnosed with allergic contact dermatitis, either in combination with psoriasis (6 patients) or alone (1 patient). Topical glucocorticoids were the most common effective therapy used, and systemic therapies were required in nearly half of patients for successful treatment. Conclusion: This study offers insights into the clinically and histopathologically challenging diagnosis of psoriasis vulgaris with eczematous changes and offers the diagnostic term “eczematized psoriasis” to describe these patients. The presence of allergic contact dermatitis should be considered in these patients.


1 July 2021 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
MCMaressa C. Criscito
Maressa C. Criscito
JCJeffrey M. Cohen
Jeffrey M. Cohen
STSiavash Toosi
Siavash Toosi
LPLauren A. Penn
Lauren A. Penn
CRCasey L. Ross
Casey L. Ross
NBNooshin K. Brinster
Nooshin K. Brinster

1 January 2018 in Dermatology Online Journal
Verified
Journal Article
Open access
PDF file
JWJason F Wang
Jason F Wang
LMLaura E Melnick
Laura E Melnick
LPLauren A Penn
Lauren A Penn
NBNooshin K Brinster
Nooshin K Brinster
VOVikash S OzaMD
Vikash S OzaMD
Cutaneous Crohn disease (CCD) is a rare dermatologic manifestation of Crohn disease and is defined as noncaseating, granulomatous skin lesions noncontiguous with the gastrointestinal tract. It most commonly affects the skin of the legs, although genital CCD is the most common presentation in children. Diagnosis of CCD is made by a combination of clinical and histopathological findings. Therapeutic options include topical, intralesional, and systemic corticosteroids as well as topical and systemic immunosuppressants and immunomodulators. Surgical excision may be considered for refractory cases. We report CCD in a 9-year old boy with penile swelling, granulomatous cheilitis-like lesions, and perianal plaques.